<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvestb</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Башкортостана</journal-title><trans-title-group xml:lang="en"><trans-title>Bashkortostan Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1999-6209</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medvestb-1089</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>МОРФОЛОГИЧЕСКАЯ ОЦЕНКА СУММЫ БАЛЛОВ ПО ШКАЛЕ ГЛИСОНА ДО И ПОСЛЕ РАДИКАЛЬНОЙ ПРОСТАТЭКТОМИИ</article-title><trans-title-group xml:lang="en"><trans-title>MORPHOLOGICAL EVALUATION OF THE GLYSON SUM BEFORE AND AFTER RADICAL PROSTATECTOMY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щекин</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Schekin</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щекин Влас Сергеевич – зав. научно-морфологической лабораторией Института фундаментальной медицины </p><p>450008, г. Уфа, ул. Ленина, 3. E-mail: vlas-s@mail.ru </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутлияров</surname><given-names>Л. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutliyarov</surname><given-names>L. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кутлияров Линат Минихамович – к.м.н., доцент кафедры урологии </p><p>450008, г. Уфа, ул. Ленина, 3 </p></bio><email xlink:type="simple">lmkutliyarov@bashgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терегулов</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Teregulov</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терегулов Ильдар Ильшатович – м.н.с. научно-морфологической лаборатории Института фундаментальной медицины</p><p>450008, г. Уфа, ул. Ленина, 3 </p></bio><email xlink:type="simple">iiteregulov@bashgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власова</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasova</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Власова Ангелина Олеговна – м.н.с. научно-морфологической лаборатории Института фундаментальной медицины</p><p>450008, г. Уфа, ул. Ленина, 3</p></bio><email xlink:type="simple">aovlasova@bashgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2025</year></pub-date><volume>19</volume><issue>1</issue><fpage>13</fpage><lpage>17</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Щекин В.С., Кутлияров Л.М., Терегулов И.И., Власова А.О., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Щекин В.С., Кутлияров Л.М., Терегулов И.И., Власова А.О.</copyright-holder><copyright-holder xml:lang="en">Schekin V.S., Kutliyarov L.M., Teregulov I.I., Vlasova A.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvestb.elpub.ru/jour/article/view/1089">https://medvestb.elpub.ru/jour/article/view/1089</self-uri><abstract><p>Рак предстательной железы входит в число широко распространенных злокачественных новообразований у мужчин. На сегодняшний день в России рак простаты встречается в 15,1% случаев среди всех онкологий у мужчин. Выявляемость рака простаты основывается на патоморфологической оценке тканей по системе Глисона, позволяющей оценить рост и дифференцировку опухоли. Часто обнаруживаются различия суммы баллов по шкале Глисона в образцах, полученных при биопсии и после радикальной простатэктомии.Материал и методы. В данной работе представлен сравнительный анализ суммы баллов по шкале Глисона в образцах после полифокальной биопсии и радикальной простатэктомии у 50 пациентов Клиники Башкирского государственного медицинского университета в 2023 году.Результаты. В 59,4% случаев результаты исследования биопсийного материала предстательной железы совпадали с данными суммы баллов по шкале Глисона после простатэктомии, в 13,5% случаев наблюдалось снижение показателей суммы баллов по шкале Глисона и в 27% случаев отмечалось их увеличение.Заключение. Понижение суммы баллов по шкале Глисона после проведения простатэктомии ассоциируется с более благоприятным прогнозом выживаемости, в свою очередь повышение градации, в частности за счет компонента Глисона 4, в большинстве случаев расценивается как прогностический фактор биохимического рецидива и раково-специфической смертности. Особенно важна микроскопическая характеристика, отражающая лимфоваскулярную инвазию и экстрапростатическое распространение, что может оказывать влияние на стадирование рака простаты.</p></abstract><trans-abstract xml:lang="en"><p>Prostate cancer is one of the most widespread malignant neoplasms in men and today in Russia prostate cancer occurs in 15.1% of all cancers in men. The detection of prostate cancer is based on a pathomorphological assessment of tissues using the Gleason system, which allows to assess the growth and differentiation of the tumor. It is often possible to detect differences between biopsy and radical prostatectomy samples in terms of changes in the amount of points on the Gleason scale.Material and methods. In this paper, we comparatively analyzed the sum of Gleason scores after a multifocal biopsy and radical prostatectomy in 50 patients of the Bashkir State University Clinic in 2023.Results. In 59.4% of cases, the results of the examination of prostate biopsy material coincided with the results after prostatectomy according to the sum of points on the Gleason scale, in 13.5% of cases there was a decrease and in 27% of cases there was an increase.Conclusion. A decrease in the Gleason score after prostatectomy is associated with a more favorable prognosis of survival, in turn, an increase in graduation, in particular, due to the Gleason component 4, in most cases is regarded as a prognostic factor of biochemical recurrence and cancer-specific mortality. In particular, microscopic characteristics reflecting lymphovascular invasion and extraprostatic spread are important, which may affect the staging of prostate cancer.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак предстательной железы</kwd><kwd>полифокальная биопсия простаты</kwd><kwd>сумма баллов по Глисону</kwd><kwd>радикальная простатэктомия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>prostate cancer</kwd><kwd>polyfocal prostate biopsy</kwd><kwd>Gleason sum</kwd><kwd>radical prostatectomy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена за счет средств Программы стратегического академического лидерства Башкирского государственного медицинского университета (ПРИОРИТЕТ-2030).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">International variation in prostate cancer incidence and mortality rates / M.M. Center [et al.]// Eur Urol. – 2012. – Vol.61, №6. – P. 1079-92.</mixed-citation><mixed-citation xml:lang="en">Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012 Jun;61(6):1079-92. (in Engl) doi: 10.1016/j.eururo.2012.02.054.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Чиссов, В.И. Злокачественные новообразования в России в 2011 году (заболеваемость и смертность)/ В.И. Чиссов, В.В. Старинский, Г.В. Петрова. – М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России. – 2013 – C. 289</mixed-citation><mixed-citation xml:lang="en">Chissov V.I., Starinsky V.V., Petrova G.V. Zlokachestvennye novoobrazovanija v Rossii v 2011 godu (zabolevaemost' i smertnost') (Malignant neoplasms in Russia in 2011 (morbidity and mortality)). Moscow: FGBU «MNIOI im. P.A. Gercena» Minzdrava Rossii. 2013: 289. (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Carlsson, SV. Screening for Prostate Cancer/ SV Carlsson, AJ. Vickers // Med Clin North Am. – 2020. – Vol.104, №6. – P. 1051-1062.</mixed-citation><mixed-citation xml:lang="en">Carlsson SV, Vickers AJ. Screening for Prostate Cancer. Med Clin North Am. 2020 Nov;104(6):1051-1062. (in Engl) doi: 10.1016/j.mcna.2020.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн, А.Д. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность)/ А.Д. Каприн, В.В. Старинский, А.О. Шахзадова. – М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. – 252 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Zlokachestvennye novoobrazovanija v Rossii v 2021 godu (zabolevaemost' i smertnost') (Malignant neoplasms in Russia in 2021 (morbidity and mortality)). Moscow: MNIOI im. P.A. Gercena - filial FGBU «NMIC radiologii» Minzdrava Rossii, 2022:252. (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">AUA Prostate Cancer Clinical Guideline Update Panel. Guideline for the management of clinically localized prostate cancer/ I. Thompson [et al.]// J Urol. – 2007. – Vol.177, №6. – P. 2106-31.</mixed-citation><mixed-citation xml:lang="en">Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM; AUA Prostate Cancer Clinical Guideline Update Panel. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007 Jun;177(6):2106-31. (in Engl) doi: 10.1016/j.juro.2007.03.003.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease/ A. Heidenreich [et al.] // Eur Urol. – 2011. – Vol. 59, № 1. – P. 61-71.</mixed-citation><mixed-citation xml:lang="en">Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F; European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol. 2011 Jan;59(1):61-71. (in Engl) doi: 10.1016/j.eururo.2010.10.039.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сравнительный анализ гистологических данных до и после радикальной простатэктомии у больных с низким дооперационным онкологическим риском/ Ю.Г. Аляев [и др.]// Андрология и генитальная хирургия. – 2015. – Т.16, №4. – С.46-50.</mixed-citation><mixed-citation xml:lang="en">Alyaev Y.G., Varshavsky V.A., Rapoport L.M., Tsarichenko D.G., Enikeev M.E., Korolev D.O., Fokin I.V. Comparative analysis of histologic data before and after radical prostatectomy in patients with low preoperative oncologic risk. Andrology and Genital Surgery. 2015;16(4):46-50. (in Russ) https://doi.org/10.17650/2070-9781-2015-16-4-46-50</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Новая классификация ВОЗ опухолей предстательной железы / Г.А. Франк [и др.] // Архив патологии. – 2016. – Т.78, № 4. – С. 32-42.</mixed-citation><mixed-citation xml:lang="en">Frank G.A., Andreeva Y.Y., Moskvina L.V., Efremov G.D., Samoylova S.I. New WHO classification of prostate tumors. Archives of Pathology. 2016;78(4):32-42. (in Russ) https://doi.org/10.17116/patol201678432-42.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Горбань, Н.А. Трепанобиопсия предстательной железы / Н.А., Горбань, А.Г. Кудайбергенова. – М.: ИД «АБВ-пресс», 2017. – С.101-117.</mixed-citation><mixed-citation xml:lang="en">Gorban N.A., Kudaibergenova A.G. Trepanobiopsija predstatel'noj zhelezy (Trepanobiopsy of the prostate gland: a morphologist's view). Moscow: ID "ABB-press"; 2017:101-117.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 5.1// Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) – Berlin, 2019. – 352 р.</mixed-citation><mixed-citation xml:lang="en">Guideline Program Oncology (German Cancer Society, German Cancer Aid, AWMF) Interdisciplinary guideline of quality S3 for early detection, diagnosis and therapy of the different stages of prostate cancer, long version 5.1, Berlin 2019: 352. (in Germany)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy / MC. Schumacher [et al.] // Eur Urol. – 2008. – Vol. 54, № 344. – P. 352.</mixed-citation><mixed-citation xml:lang="en">Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol. 2008;54:344–352. (in Engl) DOI: 10.1016/j.eururo.2008.05.023</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review./ N. Fossati [et al.] // Eur Urol. – 2017. – Vol.72, №1. – P.84-109.</mixed-citation><mixed-citation xml:lang="en">Fossati N, Willemse PM, Van den Broeck T, van den Bergh RCN, Yuan CY, Briers E, [et al.] The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol. 2017 Jul;72(1):84-109. (in Engl) doi: 10.1016/j.eururo.2016.12.003.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens./ P. Swindle [et al.] // J Urol. – 2008. – Vol.179, № 5. – P. 47-51.</mixed-citation><mixed-citation xml:lang="en">Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, [et al.] Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 2008 May;179(5 Suppl):S47-51. (in Engl) doi: 10.1016/j.juro.2008.03.137.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Options for Curative Treatment of Localized Prostate Cancer./ S. Knipper [et al.] // Dtsch Arztebl Int. – 2021. – Vol. 2, № 118. – P. 228-236.</mixed-citation><mixed-citation xml:lang="en">Knipper S, Ott S, Schlemmer HP, Grimm MO, Graefen M, Wiegel T. Options for Curative Treatment of Localized Prostate Cancer. Dtsch Arztebl Int. 2021 Apr 2;118(Forthcoming):228–36. (in Engl) doi: 10.3238/arztebl.m2021.0026.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Оценка факторов гетерогенности рака предстательной железы низкой степени злокачественности у пациентов до и после радикальной простатэктомии / Е.И. Велиев [и др.] // Онкоурология. – 2020. – Т.16, №3. – С.70-9.</mixed-citation><mixed-citation xml:lang="en">Veliev E.I., Goncharuk D.A., Sokolov E.A. [et al.] Evaluation of heterogeneity factors of low-grade malignancy prostate cancer in patients before and after radical prostatectomy. Oncourology 2020;16(3):70-9. (in Russ) https://doi.org/10.17650/10.17650/1726-9776-2020-16-3-70-79</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tavangar, S.M. Correlation between prostate needle biopsy and radical prostatectomy Gleason gradings of 111 cases with prostatic adenocarcinoma./ S.M. Tavangar, A. Raz, R. Mashayekhi // Urol J – 2004. – Vol.1, №4. – P.246-249.</mixed-citation><mixed-citation xml:lang="en">Tavangar S.M., Raz A., Mashayekhi R. Correlation between prostate needle biopsy and radical prostatectomy Gleason gradings of 111 cases with prostatic adenocarcinoma. Urol J 2004;1(4):246–9. (in Engl)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens / BY. Shen [et al.]// Chang Gung Med J. – 2003. – Vol.26, №12. – P.919.</mixed-citation><mixed-citation xml:lang="en">Shen BY, Tsui KH, Chang PL, Chuang CK, Hsieh ML, Huang ST, [et al.] Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens. Chang Gung Med J. 2003 Dec;26(12):919-24. (in Engl)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Localized prostate cancer and robot-assisted laparoscopic radical prostatectomy: a retrospective, comparative study between pre- and post-operative Gleason scores./ MMEL. Henderickx // Acta Chir Belg. – 2018. –Vol.118, №1. – P.15-20.</mixed-citation><mixed-citation xml:lang="en">Henderickx MMEL, Brits T, Muilwijk T, Adams T, Vandeursen H. Localized prostate cancer and robot-assisted laparoscopic radical prostatectomy: a retrospective, comparative study between pre- and post-operative Gleason scores. Acta Chir Belg. 2018 Feb;118(1):15- 20. (in Engl) doi: 10.1080/00015458.2017.1353234.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lavery, H.J. Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?/ H.J. Lavery, M.J. Droller // J Urol – 2012. – Vol.188, №15. – P.1667-1675.</mixed-citation><mixed-citation xml:lang="en">Lavery H.J., Droller M.J. Do Gleason patterns 3 and 4 prostate cancer represent separate disease states? J Urol 2012; 188(5):1667–75. (in Engl) DOI: 10.1016/ j.juro.2012.07.055.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
